advertisement
14 Costing studies; pharmacoeconomics (22)
Showing records 1 to 22
Display all abstracts in classification 14 Costing studies; pharmacoeconomics
Search within classification 14 Costing studies; pharmacoeconomics
86349 Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational studyWaterman H
British Journal of Ophthalmology 2020; 104: 1704-1709
86574 Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017Bartlett VL
Journal of managed care & specialty pharmacy 2020; 26: 562-567
86785 Influence of Cost of Care and Adherence in Glaucoma Management: An UpdateMeier-Gibbons F
Journal of Ophthalmology 2020; 2020: 5901537
86302 Assessing Health Care Burden in Glaucoma Patients with and Without Physical or Mental ComorbiditiesSerbin M
Journal of managed care & specialty pharmacy 2020; 26: 325-331
86166 Health Economic Analysis in GlaucomaPark I
Journal of Glaucoma 2020; 29: 304-311
86784 The Use of Generic Medications for GlaucomaTatham AJ
Journal of Ophthalmology 2020; 2020: 1651265
86785 Influence of Cost of Care and Adherence in Glaucoma Management: An UpdateTöteberg-Harms M
Journal of Ophthalmology 2020; 2020: 5901537
86166 Health Economic Analysis in GlaucomaGale J
Journal of Glaucoma 2020; 29: 304-311
86349 Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational studyRead S
British Journal of Ophthalmology 2020; 104: 1704-1709
86574 Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017Liu P
Journal of managed care & specialty pharmacy 2020; 26: 562-567
86302 Assessing Health Care Burden in Glaucoma Patients with and Without Physical or Mental ComorbiditiesDevine B
Journal of managed care & specialty pharmacy 2020; 26: 325-331
86166 Health Economic Analysis in GlaucomaSkalicky SE
Journal of Glaucoma 2020; 29: 304-311
86302 Assessing Health Care Burden in Glaucoma Patients with and Without Physical or Mental ComorbiditiesCampbell J
Journal of managed care & specialty pharmacy 2020; 26: 325-331
86349 Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational studyMorgan JE
British Journal of Ophthalmology 2020; 104: 1704-1709
86574 Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017Dhruva SS; Shah ND
Journal of managed care & specialty pharmacy 2020; 26: 562-567
86349 Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational studyGillespie D
British Journal of Ophthalmology 2020; 104: 1704-1709
86302 Assessing Health Care Burden in Glaucoma Patients with and Without Physical or Mental ComorbiditiesBasu A
Journal of managed care & specialty pharmacy 2020; 26: 325-331
86349 Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational studyNollett C
British Journal of Ophthalmology 2020; 104: 1704-1709
86574 Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017Bollinger KE
Journal of managed care & specialty pharmacy 2020; 26: 562-567
86349 Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational studyAllen D
British Journal of Ophthalmology 2020; 104: 1704-1709
86574 Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017Ross JS
Journal of managed care & specialty pharmacy 2020; 26: 562-567
86349 Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational studyWeiss M; Anderson P
British Journal of Ophthalmology 2020; 104: 1704-1709
Issue 21-2
Change Issue
advertisement